/PRNewswire/ Celloram Inc., a dynamic biotech startup based in Cleveland, Ohio and developing novel medicines for cancer and immune disorders, announced.
Celloram, which is developing novel medicines for cancer and immune disorders, said it entered into a licensing deal with biopharmaceutical company GENFIT to partner on combating liver disease.
Ann Arbor, Michigan (PRWEB) December 15, 2022 ANN ARBOR, MI, DECEMBER 2, 2022 Cayman joins the Cayman Biomedical Research Institute (CABRI) in recognizing
Every year, more than 100 kids in Northeast Ohio enter the doors of University Hospitals Rainbow Babies and Children’s Hospital only to find out they have cancer.